Synergistic function of Smad4 and PTEN in suppressing forestomach squamous cell carcinoma in the mouse

Y Teng, AN Sun, XC Pan, G Yang, LL Yang, MR Wang… - Cancer research, 2006 - AACR
Y Teng, AN Sun, XC Pan, G Yang, LL Yang, MR Wang, X Yang
Cancer research, 2006AACR
The genetic bases underlying esophageal tumorigenesis are poorly understood. Our
previous studies have shown that coordinated deletion of the Smad4 and PTEN genes
results in accelerated hair loss and skin tumor formation in mice. Herein, we exemplify that
the concomitant inactivation of Smad4 and PTEN accelerates spontaneous forestomach
carcinogenesis at complete penetrance during the first 2 months of age. All of the
forestomach tumors were invasive squamous cell carcinomas (SCCs), which recapitulated …
Abstract
The genetic bases underlying esophageal tumorigenesis are poorly understood. Our previous studies have shown that coordinated deletion of the Smad4 and PTEN genes results in accelerated hair loss and skin tumor formation in mice. Herein, we exemplify that the concomitant inactivation of Smad4 and PTEN accelerates spontaneous forestomach carcinogenesis at complete penetrance during the first 2 months of age. All of the forestomach tumors were invasive squamous cell carcinomas (SCCs), which recapitulated the natural history and pathologic features of human esophageal SCCs. A small population of the SCC lesions was accompanied by adenocarcinomas at the adjacent submucosa region in the double mutant mice. The rapid progression of forestomach tumor formation in the Smad4 and PTEN double knockout mice corresponded to a dramatic increase in esophageal and forestomach epithelial proliferation. The decreased expression of p27, p21, and p16 together with the overexpression of cyclin D1 contributed cooperatively to the accelerated forestomach tumorigenesis in the double mutant mice. Our results point strongly to the crucial relevance of synergy between Smad4 and PTEN to suppress forestomach tumorigenesis through the cooperative induction of cell cycle inhibitors. (Cancer Res 2006; 66(14): 6972-81)
AACR